Promacta — Medica
Thrombocytopenia in a patient with chronic hepatitis C
Initial criteria
- Patient has low platelet counts at baseline (pretreatment)
- Patient will be receiving interferon-based therapy for chronic hepatitis C (e.g., pegylated interferon, Pegasys, PegIntron, Intron A)
- Medication is prescribed by or in consultation with a gastroenterologist, hepatologist, or infectious disease specialist
Approval duration
1 year